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ABSTRACT
The endocrine pancreas is responsible for maintaining glycemic equilibrium in the
body. Given the importance of this blood-glucose homeostasis and the implication an
unbalance has on Diabetes mellitus, the study of the glucose-sensing alpha and beta cells
in the pancreas is a popular field for scientific researchers. In this study, we use
immunofluorescence, qPCR analysis, intracellular calcium experiments, and biochemical
glucagon secretion assays to determine if the commercially available tumor cell line
clone, α-TC1-6 obtained from American Type Culture Collection, is an appropriate
model system for glucagon secretion in pancreatic alpha cells. We confirm the production
of the hormone peptide glucagon as well as increased intracellular calcium activity
associated with a decrease in extracellular glucose. However, the resultant stimulated
secretion of glucagon at low glucose levels is much less than expected from an endocrine
cell and indicates deficiency of the pathway. The American Type Culture Collection αTC1-6 cell line also retains the activity of the KATP channel and an agatoxin-sensitive
P/Q-type calcium channel, but does not exhibit activity of a TTX-sensitive sodium
channel and lacks the expression of the receptor of a key paracrine regulator, epinephrine.
Paracrine control via an increase in cytosolic cAMP is observed but not coupled with
glucagon secretion. Due to these shortcomings, the ATCC α-TC1-6 cell line is not a good
model system for the study of regulated glucagon secretion in pancreatic alpha cells.
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INTRODUCTION
Approximately 10% of the American population is living with diabetes. With 1.5
million new cases diagnosed each year, diabetes has become an epidemic in the United
States as well as the rest of the world (Sheik Abdulazeez 2015). Due to this statistic,
many researchers are working to control the physiological effects of the disease through
an increased understanding of the secretion mechanisms behind the specialized cells of
the pancreas responsible for the maintenance of glucose homeostasis. Type 1 and type 2
diabetes have been characterized by the body’s inability to respond to high blood-glucose
levels with the secretion of appropriate amounts of insulin bringing the blood glucose
levels to a normal range. However, recent research has indicated that unregulated
glucagon secretion by the alpha cells plays a major role in the progression of diabetes
(Lee et al. 2011). In type 1 diabetes, this is due to an autoimmune destruction of the beta
cells, while type 2 diabetes is characterized by the impairment of the beta cells. Both
cases lead to inefficient secretion of insulin and uncontrolled secretion of glucagon
(Frandsen et al. 2016).
Regulation of Blood-Glucose by the Pancreas
A change in glycemic equilibrium is detected in the pancreas by a group of cells
called the islets of Langerhans. The islets of Langerhans make up 1-2% of the pancreas
and are comprised of four main cell types, each responsible for secreting a specific
endocrine hormone (Rorsman and Braun 2013). Beta cells secrete insulin; alpha cells
1

secrete glucagon; delta cells secrete somatostatin; PP cells secrete pancreatic
polypeptides; and epsilon cells secrete ghrelin. In rodents, the β-cells are in highest
abundance at 60-80%, followed by the α-cells at 15-20%, with delta and PP cells in low
abundance at <10% and <1%, respectively. The architecture of the islets varies greatly
between species. In laboratory mice and rats, the β-cells are found in a cluster at the
center of the islet, while the other cell types are dispersed throughout the mantle of the
islet. Conversely, in human islets, there is no β-cell core as all of the cells are distributed
evenly throughout the islet (Steiner et al. 2010). The islet is also highly vascularized.
receiving approximately 10% of the total pancreatic blood supply (Rorsman and Braun
2013). These five cell types work in coordination to sustain biological blood-glucose
equilibrium.
An increase in blood-glucose levels in the body, or hyperglycemia, stimulates the
β-cells to secrete insulin, which in turn stimulates glucose absorption by the tissues for
storage and lipid synthesis, thereby resulting in a drop in the amount of glucose
circulating in the blood. Conversely, when there is a drop in normal blood-glucose levels,
or hypoglycemia, it is detected in the pancreas by the alpha cells, which then secrete
glucagon. Glucagon stimulates the release of glucose from glycogen stores in adipose
cells, muscle cells, and the liver, resulting in an increase in blood glucose. Working in
coordination, these two hormones are largely responsible for sustaining biological
glycemic equilibrium.
Type 1 and type 2 diabetes are characterized by the body’s inability to respond to
high blood-glucose levels by secreting the appropriate amounts of insulin necessary for
bringing the blood-glucose levels into the normal range. In type 1 diabetes, this is due to
2

an autoimmune destruction of the beta cells (Sheik Abdulazeez 2015). In type 2 diabetes,
an impairment of the beta cells causes ineffective insulin synthesis, and the body is
unable to respond to insulin appropriately (Sheik Abdulazeez 2015). Following the
rediscovery of the role of glucagon in diabetes, there is renewed interest in researching
glucagon secretion by alpha cells (Moon and Won 2015). A recent study revealed that
glucagon-receptor-knockout mice, whose beta cells were destroyed with streptozotocin,
were able to maintain normal glycemic levels in the blood (Lee et al. 2011). In other
words, animals that were incapable of producing insulin due to of the loss of β-cells and
that could not respond to the release of glucagon from α-cells because of the absence of
the glucagon receptor had circulating blood-glucose levels that remained stable. The
implication of these observations is that the regulation of glucagon secretion by the alpha
cell is as important for the management of diabetes as the regulation of insulin secretion
by the beta cells.
Physiology of the Pancreatic Beta Cell
Glucose-regulated Insulin Secretion
The mechanism of glucose-induced insulin secretion in the beta cell has been well
studied and is largely understood. At high glucose concentrations, glucose enters through
the GLUT2 transporter in the plasma membrane and is metabolized, resulting in an
increase in the adenosine triphosphate/adenosine diphosphate (ATP/ADP) ratio in the cell
which triggers closure of the ATP-sensitive potassium (KATP) channel. This closure of the
KATP channel leads to depolarization of the membrane and the opening of voltage-gated
L-type Ca2+ channels, resulting in an influx of calcium and the release of docked
secretory granules containing insulin. Once secreted, insulin initiates cellular uptake of
3

glucose at fat, liver, and skeletal muscle cells and the incorporation of glucose moieties
into glycogen in the cytoplasm for storage (Rorsman and Braun 2013).
Physiology of the Pancreatic Alpha Cell
In contrast to the beta cell, how the alpha cell regulates glucagon secretion is
highly debated and not well understood. The regulation of secretion appears to be
complex, and current research indicates that there are multiple possible mechanisms. The
theories are approached from two perspectives: the intrinsic response to circulating levels
of glucose and the influence of paracrine and endocrine factors (Rorsman et al. 2014b).
Glucose-regulated Glucagon Secretion
In low glucose conditions, glucagon secretion is increased due to low activity of
KATP channels, which results in the firing of large-amplitude action potentials. Brief or
partial opening of KATP channels hyperpolarizes the membrane to a negative membrane
potential and removes the nearby Tetrodotoxin-sensitive Na+ channel inactivation.
Opening of voltage-gated T-type Ca2+ channels depolarizes the membrane. When the
membrane potential reaches action potential threshold, a large population of P/Q-type
channels is able to enter the conductive state, triggering calcium influx and glucagon
secretion (Göpel et al. 2000). Alternatively, in high glucose conditions an increased
cytosolic ATP/ADP ratio causes the closure of KATP channels, keeping the membrane
potential depolarized below action potential threshold. At this depolarized potential, a
large portion of T-type Ca2+ channels and Tetrodotoxin-sensitive Na+ channels are
inactive and enter a nonconductive state. Consequently, low-amplitude action potential
spikes are generated and the reduced Ca2+ influx is insufficient to trigger glucagon
secretion (Figure 1) (Gromada et al. 2004).
4

Adapted from: Ashcroft, F.M. and Rorsman, P.
Nat.Rev.Endocrinol. 9, 660-669 (2013)

Figure 1: Glucose-regulated glucagon secretion (Ashcroft and Rorsman 2013).
Paracrine, Autocrine, and Endocrine Regulation of the Alpha Cell
The spatial distribution of alpha cells in the islet, the high level of vascularization,
and innervation allow for alpha cells to be regulated by nutrients, hormones, and
neurotransmitters (Brereton et al. 2015). Insulin and zinc from the β-cell have been
shown to be important paracrine regulators of alpha cells. Glucagon secretion is inhibited
via the PIK3 pathway as well as the alteration in the sensitivity of the KATP channel (Lee
et al. 2011). Somatostatin, which is produced in islet δ-cells as well as other tissues, has
been shown to inhibit glucagon secretion and insulin secretion. Glucagon itself can also
exert control via an autocrine positive-feedback mechanism that stimulates secretion by
increasing exocytosis-associated cAMP. GLP-1 from beta cells and L-cells in the
stomach also act via GPCR, elevating cAMP levels and resulting in the suppression of
glucagon. Alternatively, epinephrine, again acting through the cAMP pathway, increases
glucagon secretion. The neurotransmitter γ-aminobutyric acid (GABA) is released by the
5

beta cell and activates GABAA receptors on the alpha cell. Activation of these receptors
is coupled to inward chloride currents that hyperpolarize the alpha cell membrane and
therefore decrease glucagon secretion. In addition, the neurotransmitter L-glutamate is
co-secreted with glucagon, triggering GABA release from β-cells and resulting in a
decrease in glucagon secretion (Figure 2).

Quesada I et al. J Endocrinology 2008;199:5-19

Figure 2: Autocrine, paracrine, and neuroendocrine regulation of the alpha cell
(Quesada et al. 2008).
cAMP Pathways in Endocrine Cells
Many of the paracrine signals that regulate glucagon secretion do so via the
second messenger, cAMP (Figure 2). This occurs through G-protein coupled receptors
6

(GPCR) that initiate the signaling cascade that generates cAMP. Following the activation
of the GPCR by the ligand, the Gs-alpha subunit dissociates from the β and γ subunits and
exchanges GDP for GTP. The now activated Gs-alpha subunit binds to adenylyl cyclase
(AC), causing the catalytic conversion of ATP to cyclic adenosine monophosphate
(cAMP). cAMP, now a second messenger, is able to activate the PKA and Epac
pathways.
Protein kinase A (PKA) is a tetramer consisting of two catalytic subunits and two
cAMP binding sites. Four molecules of cAMP are required to induce the conformational
change that results in the regulatory subunits dissociating from the activated catalytic
subunits. Once activated, these catalytic subunits are capable of phosphorylating target
proteins, including ion channels, enzymes, and transcription factors (Wu et al. 2015).
Epac (exchange protein activated by cAMP) is a cAMP-regulated guanine
nucleotide exchange factor (GEF) (Holz, 2004). Two isoforms, Epac1 and Epac2, have
been discovered and exhibit different affinities for cAMP binding. Both isoforms of Epac
are multi-domain proteins containing an N-terminal regulatory domain and a C-terminal
catalytic domain, which is the site for cAMP binding. The Epac isoforms act as GEFs for
the GTPases Rap1 and Rap2. The nucleotide exchange is initiated by the binding of
cAMP to the catalytic domain of the protein (Bos, 2006).
Ca2+-induced Glucagon Secretion in Pancreatic Alpha Cells
Due to the important role endocrine peptides and hormones play in maintaining
homeostasis, their secretion occurs through the regulated secretory pathway. The message
for propeptides and prohormones is first translated in the rough endoplasmic reticulum.
The peptide is then transferred to the Golgi apparatus for further processing and finally
7

packaged into dense-core vesicles (DCV) (Lin and Salton 2013). The exocytosis of DCV
and secretion of hormone is tightly controlled by both Ca2+ and cAMP, signaling
pathways within the endocrine cells. In alpha cells, synaptotagmin 7 (SYT7) functions as
the primary Ca2+-sensor for exocytosis and acts via Ca2+-dependent interactions with both
the fusing of phospholipid membranes and the membrane fusion machinery (Gustavsson
et al. 2009a).
In order to study the many facets of pancreatic alpha cell secretion, we used the
Alpha TC1.6 immortal cell line clone purchased from American Type Culture Collection
(ATCC).
Usage of Immortal Cell Lines for Biological Study
The usage of immortal cell lines for biological study is appealing to scientists
because they are easy to obtain, offer an unlimited supply of cells, are cost effective, and
avoid the ethical concerns of using animal and human tissue. American Type Culture
Collection (ATCC) has stock of over 3,600 cell lines from over 150 different species
(Kaur and Dufour 2012). Despite the many advantages of using cell lines for study, there
are also drawbacks. In order for a cell line to be considered an appropriate model system,
the cell line must retain many of the same functional characteristics of the primary cell
and be properly maintained to preserve these characteristics (Geraghty et al. 2014).
Study of Pancreatic Alpha Cell Line Clone Alpha TC1.6
Alpha TC1.6 is one of the pancreatic alpha clones derived from an adenoma
created in transgenic mice expressing the SV40 large T antigen oncogene under the
control of the rat preproglucagon promoter. Previous literature indicates the presence of
high levels of glucagon and a proglucagon fragment, glucagon-like peptide I (GLP-1), the
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presence of processing enzyme PC2 ((Powers et al. 1990) and tissue specific homeotic
genes in alpha TC1.6 cells (Mizusawa et al. 2004), as well as the evidence of insulin
inhibition of glucagon secretion (Shen et al. 2012).
Previously in our lab, experiments were performed using the alpha TC1.6 clone
obtained from Dr. Don Steiner (University of Chicago). This clone was used to study
intracellular calcium activity and cAMP activity associated with the melanocortin 4
receptor (Liang 2009), as well as cAMP production and the presence of
phosphodiesterases (Crane 2011). However, this clone of alpha TC1.6 cells is no longer
available.
The objective of my research was to test the hypothesis that the current alpha
TC1.6 clone available through the American Type Culture Collection (ATCC) has the
same properties as the alpha TC1.6 clone provided to our lab by Dr. Steiner several years
ago. To this end, we will analyze the relative expression of genes crucial for glucagon
secretion, the intracellular calcium activity and biochemical glucagon secretion at
different extracellular glucose concentrations, and the intracellular calcium activity and
secretion in the presence of pharmacological drugs that modulate cAMP levels and ion
channel activity.
The subsequent experiments outlined in this thesis help characterize glucagon
secretion in a commercially available alpha TC1.6 clone from American Type Culture
Collection (ATCC).

9

METHODS
Cell Culture
Mouse pancreatic α cell line αTC1-6 cells (American Type Culture Collection,
ATCC, purchased in 2014, Manassas, VA) were cultured in DMEM containing 15 mM
glucose, 10% heat-inactivated fetal bovine serum, 1.0 mM sodium pyruvate, 100 unit/ml
penicillin, 100 µg/ml streptomycin, 100 µg/ml normacin, and MEM non-essential amino
acids and maintained in a humidified incubator with 95% air and 5% CO2 at 37 °C.
Islet Dissociation and Culture
Mouse pancreas was perfused with 4 mL (1,000 U ml-1) collagenase in HBSS via
the joint site of the hepatic duct and cystic duct. (All procedures were approved by
University of Denver, IACUC.) The pancreas was removed and digested in 1 mL of
collagenase for 15 minutes at 37 °C. Adding ice-cold 1mM CaCl2 in 1x HBSS terminated
collagenase digestion. Islets were handpicked and plated on tissue culture dishes. Islets
were cultured until use at 37 °C in RPMI medium containing 10.4 mg/L-glutamate, 10%
FBS, 10 mM HEPES, 1 mM Na pyruvic acid, 7 µl/L ß-mercaptoethanol, 1% pen/strep,
and 3.7 g/L sodium bicarbonate.
Immunofluorescence
For single cell immunofluorescence experiments, the ATCC αTC1-6 cells were
plated in 8-well chamber slides. After 24 hours, the cells were fixed with a 4% PFA
solution for 20 minutes, and then all wells were washed with a 1xPBS solution. The cells
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were then permeablized with 0.4% Triton X-100/1X PBS for 15 minutes, followed by a
blocking step (20% donkey serum, 1% BSA, in 1X PBS) for 30 minutes at room
temperature. Next, the primary antibody was added in 1X PBS with 10% donkey serum
and 5% BSA, and the cells were incubated in a humidified chamber at 40 ºC for 90
minutes. After three washes with 1X PBS, cells were incubated at RT for 45 minutes with
the secondary antibody in 1X PBS with 20% donkey serum and 1% BSA. After three
washes with 1X PBS, the slides were mounted with Vecta-Shield + DAPI (Vector
Laboratories Inc., Burlingame, CA) and coverslips were applied to the slides and sealed
with clear nail polish. The slides were imaged using a laser-scanning Olympus FluoView
FV1000 confocal microscope using the 60x oil objective (N.A. 1.42).
Isolated islets were immunostained in solution. First they were fixed in 4% PFA
for 15 minutes at RT, followed by a wash with 1X PBS. The cells were then
permeablized with 0.4% Triton X-100/1X PBS for 15 minutes. Next, the primary
antibody was added in 1X PBS with 10% donkey serum and 10% BSA, and the islets
were incubated overnight at 4 ºC. After three washes with 1X PBS, islets were incubated
at RT for 60 minutes with the secondary antibody in 1X PBS with 20% donkey serum
and 10% BSA. After three washes with 1X PBS, islets were affixed to ECL-coated slides,
then mounted with Vecta-Shield + DAPI (Vector Laboratories Inc., Burlingame, CA) and
coverslips were applied to the slides and sealed with clear nail polish. The slides were
imaged using a laser-scanning Olympus FluoView FV1000 confocal microscope using
the 60x oil objective (N.A. 1.42).
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mRNA Isolation and cDNA Synthesis
Prior to extracting messenger RNA (mRNA), the adherent cells were detached
using 0.25% trypsin (Thermo Fisher Scientific, Waltham, MA), pelleted low speed and
washed with 1X PBS. The mRNA was isolated using the RNAqueous-4PCR kit
(Invitrogen, Carlsbad, CA). The mRNA was then extracted and converted into
complimentary DNA (cDNA) using the SuperScript III First Strand Synthesis System for
RT-PCR (Invitrogen, Carlsbad, CA).
Quantitative Polymerase Chain Reaction (qPCR)
Thermocycling and fluorescence detection were done using a Bio-Rad iQ5 RealTime PCR Detection System linked to a PC running iQ5 Optical System Software
version 1.1. Each reaction was performed in quadruplicate. qPCR Taqman primers were
obtained from Applied Biosystems (Foster City, CA). Inventoried primers were ordered
for all genes of interest. Each qPCR reaction consisted of 10 µL Bio-Rad iQ5 2X
Supermix (Hercules, CA), 1 µL 20X primer and probe, 2 µL cDNA template, and 7 µL
DEPC treated water. Final reaction conditions were as follows: 100 ng template DNA, 50
mM KCl, 20 mM Tris-HCL, 0.8 mM deoxynucleotide triphosphates, 0.5 U iTaq DNA
polymerase, 3 mM MgCl2, and 400 nM primer and 250 nM probe. The QPCR program
consisted of 2 steps: initial denaturation for 3 minutes at 95 °C, followed by 40 cycles of
a denaturing step at 95 °C for 10 seconds and an annealing/extension step at 60 °C for 30
seconds. Fluorescence was measured at the end of every annealing/extension step. The
housekeeping gene, GAPDH, was run in quadruplicate along with all the samples.
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Relative Expression and Statistics
Relative expression was calculated using the 2ΔCt method, described in the iQ5
software manual. The calculations are:
Relative expression = 2ΔCt *10000; ΔCt = Ctcontrol – Ctsample
The control was the average Ct (threshold cycle) of the housekeeping gene and
the sample. The housekeeping gene used for all genes tested was glyceraldehyde-3phosphate dehydrogenase (GAPDH). Significance between samples was determined
using an unpaired student-T test. Results with p<0.05 were deemed significant. Statistical
tests were performed using Prism software (GraphPad Software Inc., La Jolla, CA).
Glucagon Secretion Biochemical Assay
An ANF-GFP plasmid used to monitor secretion was obtained as a gift from Dr.
Cedric Asencio (University of Denver, Denver, CO). Alpha TC1.6 cells were plated 72
hours prior to performing the secretion assay on ECL-coated (37 °C for 1 hour followed
by a serum-free media rinse) 24-well plates. A confluent flask of the adherent cells was
detached using 0.25% trypsin (Thermo Fisher Scientific, Waltham, MA), pelleted at low
speed and supernatant was removed. Cells were resuspended in 24 mL of fresh culture
media. 1 mL of the cell suspension was pipetted into each well. Plated cells were
incubated in a humidified incubator with 95% air and 5% CO2 at 37 °C. 24 hours
following plating, cells were transfected using Lipofectamine 2000 (Invitrogen, Carlsbad,
CA). Transfection conditions per reaction were as follows: 250 ng plasmid DNA, 100 µl
optimum, 2 µl Lipofectamine 2000. Solution was incubated at room temperature for 15
minutes and added to 1 well containing 500 µl of fresh culture media. Transfected cells
were incubated in a humidified incubator with 95% air and 5% CO2 at 37 °C for 48 hours.
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Following incubation period, the culture media was removed and cells were incubated at
room temperature for 30 minutes in standard resting solution. Buffer was then removed
and cells were incubated with 250 µl testing solution for 10 minutes. After incubation,
solution was immediately removed and placed into 1.5 mL micro centrifuge tubes which
were kept at 4 °C. 250 µl of lysis buffer (1% triton-x, 20 mM Tris pH 7.5, 50 mM NaCl,
protease inhibitor tablet). A 24-well plate containing cells and lysis buffer was incubated,
rotating, at 4 °C for 30 minutes. Cell lysate was removed and placed into 1.5 mL micro
centrifuge tubes. All 1.5 mL micro centrifuge tubes from both stimulation and lysis were
pelleted at 14,000 RPM for 10 minutes at 4 °C. 150 µl of each solution was pipetted into
a 96-well plate (Corning, Corning, NY) and read at 480/530 nm using a TECAN M1000
plate reader. Results were plotted as a % of total using Prism software. Significance
between samples was determined using an unpaired student-T test. Results with p<0.05
were deemed significant.
Intracellular Calcium Imaging
Alpha TC1.6 cells were plated 48 hours prior to imaging on ECL-coated (37 °C
for 1 hour followed by a serum-free media rinse) in 12 mm glass bottom imaging dishes.
Prior to imaging, culture media was removed and replaced with 5 µM Fura-2 AM
(Invitrogen, Carlsbad, CA) in standard resting solution for 30 minutes at room
temperature. Following a 30-minute incubation period, the glass dishes were thoroughly
washed with standard resting solution (1.0 mM MgCl2, 10.0 mM HEPES, 5.0 mM CaCl2,
140 mM NaCl2, 2.0 mM KCl, 8.0 mM D-glucose, at a pH of 7.2). As controls for cellular
health, a plate was imaged for total experimental time in resting glucose (8 mM) prior to
beginning experiments, and a high potassium (60 mM) solution was applied to cells via
14

perfusion following experimental imaging. All experiments were conducted at ambient
temperature (~22 ˚C). Images were acquired by 40X oil immersion objective (Zeiss) with
an inverted fluorescence Zeiss Axiovert microscope equipped with Cooke SensiCam
CCD camera. 340 nm and 380 nm excitation filters controlled by a Sutter lamda 10-2
filter wheel were used for Fura-2 AM dual excitation ratio imaging. Image pairs were
obtained every 3 seconds for 100 ms and binned with a setting of 4x4. Images were
acquired and analyzed with Slidebook software (Intelligent Imaging Innovations, Denver,
CO). Perfusions of the indicated test external solutions were performed using a gravity
flow system. All test solutions were applied after establishing baseline calcium activity.
Images from Fura-2 AM microscopy experiments were analyzed in Slidebook. Values
were exported as Microsoft Excel files and imported in Igor software (Wavemetric,
Portland, OR). All traces were blindly scored as responders and non-responders.
Pharmacology of Channel Complexes and Modulation of cAMP in Alpha Cells
Endocrine cells undergo regulated secretion in response to physiological signals
and must utilize ion channels on the plasma membrane as well as activate chemical
pathways. Following is a brief description of the pharmacological tests utilized in this
study. A summary of experimental conditions can be found in Appendix A.
cAMP
Forskolin is a biochemical activator of the enzyme adenylyl cyclase (AC), which
catalyzes the conversion of adenosine triphosphate (ATP) to the second messenger, cyclic
adenosine monophosphate (cAMP).
3-isobutyl-1-methylxanthine (IBMX) is a competitive, non-selective inhibitor of
cAMP phoshodiesterases and therefore increases cytosolic levels of cAMP.
15

8-pCPT-2'-O-Me-cAMP is a cAMP analog and Epac-selective agonist, resulting
in activation of the Epac pathway. Conversely, 6-Bnz-cAMP, also a cAMP analog, is a
PKA-selective agonist.
Voltage-gated Calcium Channel Blockers
The toxins listed below block the calcium channel activity and therefore alter the
influx of calcium ions into the cell. The voltage sensor in the α1 subunit, which forms the
Ca2+-selective pore, classifies voltage-gated calcium channels.
Conotoxins are a group of neurotoxins isolated from marine snails. Two isoforms,
ω-conotoxin CVIB and ω-conotoxin CVIC, are moderate inhibitors of P/Q-type calcium
channels as well as a less effective N-type calcium channel blocker.
ω-Agatoxin is a neurotoxin isolated from spider venom. It selectively blocks P/Qtype calcium channels.
Nifedipine is a dihydropyridine and is a high affinity L-type calcium channel
blocker.
Sodium Channel Blocker
Tetrodotoxin (TTX) is a neurotoxin that blocks the activity of voltage-gated
sodium channels, inhibiting the flow of sodium ions into the cell, and therefore prevents
of action potentials.
Potassium-sensitive Channel Modulators
The pharmaceutical drugs tolbutamide and diazoxide act via the KATP channel by
binding to the sulfonylurea receptor SUR1 to close or open the channel, respectively. As
a result, this alters the flow of potassium ions out of the cell, affecting membrane
potential.
16

RESULTS
Immunofluorescence of Glucagon in ATCC αTC1-6 Cells
Immunofluorescence was the first step in determining the efficacy of the cell line
we received from ATCC and whether or not it could be used as a model for secretion.
This was performed using an antibody against the hormone glucagon. As a control for the
primary antibody specificity to the antigen of interest, using the anti-glucagon primary
antibody at the same concentration and similar conditions as the experimental, whole
islets dissected from a wild-type FVB mouse were analyzed for the presence of glucagon
(Figure 3A). As expected, the data indicate the presence of glucagon in the anticipated
localization on the periphery of the islet from the rodent pancreas (Steiner et al. 2010). As
a control for the specificity of the secondary antibody to the primary antibody, performed
simultaneously with the experiment and under the same conditions, ATCC αTC1-6 cells
were not treated with the primary antibody against the hormone of interest (Figure 3B).
No reaction was observed for the secondary antibody, indicating that the anti-mouse
secondary antibody used is specific for the mouse glucagon primary antibody. Using a
primary antibody against the hormone glucagon on ATCC αTC1-6 cells, a strong signal
that is characteristic of endoplasmic reticulum, Golgi apparatus, and dense-core vesicle
staining was observed (Figure 3C).
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Relative Expression of Significant Genes in ATCC αTC1-6 Cells
For a cell line to be a considered a good model for secretion in pancreatic alpha
cells, it needs to express the genes of established key players of the primary cells. In
order to determine which representative genes are expressed in the ATCC αTC1-6 cells,
qPCR analysis was performed using cDNA generated from mRNA of cell lysates. As
expected, the gene encoding the intrinsic hormone glucagon was detected in high
abundance relative to the other genes tested (Figure 4).
Next, the presence of the gene encoding the ATP-sensitive potassium channel,
which is known to help maintain the resting potential and depolarization of the cellular
membrane under glucose-mediated glucagon secretion, was investigated. It is comprised
of 2 subunits: an inward rectifying (Kir6.2) subunit and a sulfonylurea-1 (SUR1) subunit.
qPCR analysis indicated the presence of the genes encoding both subunits (Figure 4).
Many hormones, including glucagon, are secreted in dense-core vesicles in a
calcium-dependent manner from alpha cells (Gustavsson et al. 2009a). SYT7 mediates
this secretion by inserting into the membrane and inducing a positive curvature of the
membrane, initiating the fusion of the vesicle membrane and the plasma membrane.
Studies have shown that SYT7 is responsible for the calcium-dependent secretion of
glucagon in alpha cells (Gustavsson et al. 2009b). qPCR analysis indicated the presence
of SYT7 in ATCC αTC1-6 cells (Figure 4).
The neurotransmitter γ-aminobutyric acid (GABA) has been shown to be a
paracrine-signaling molecule in pancreatic islets. The GABAA receptor is present on the
islet alpha cell membrane, but is not present on islet beta cells. Therefore, when released
from beta cells via Ca2+-dependent exocytosis, inhibition of glucagon secretion is
18

observed (Wendt et al. 2004). qPCR analysis of the gene GABRA1 is found to be below
detectable limits in ATCC αTC1-6 cells (Figure 4).
Electrical activity and ion channels largely regulate the secretion of glucagon. At
low glucose concentrations, the action potentials resulting from the opening of voltageactivated L- and P/Q-type Ca2+ channels, tetrodotoxin (TTX)-sensitive Na+ channels, and
KATP channels lead to increased glucagon secretion. One of these channels, the P/Q-type
Ca2+ channel has been found to be sensitive to the peptide toxin ω-agatoxin IVA
(Ramracheya et al. 2010). Therefore, we wanted to determine if this ω-agatoxin-sensitive
channel was expressed in ATCC αTC1-6 cells. The data indicate that the gene
CACNA1A was not expressed at detectable limits (Figure 4).
A previous study demonstrating the stimulatory effect of adrenaline on glucagon
secretion in primary rodent alpha cells revealed that the beta-1 adrenergic receptor and
the beta-2 adrenergic receptor were expressed in the alpha cell at a 25- and 40-fold
increase relative to beta cells (Rorsman et al. 2014c). The expression for the genes
ADRB1 and ADRB2 were below detectable limits in ATCC αTC1-6 cells (Figure 4).
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A

B

10 µm

C

Figure 3: Immunofluorescence analysis of glucagon in ATCC αTC1-6 cells. In all
experiments, nuclei were stained with DAPI and from a mouse Alexa 488 secondary
antibody (1:800) was used for visualization. (A) Intact islet of WT mouse immunostained
with a mouse anti-glucagon primary antibody (1:100). (B) ATCC αTC1-6 cells not
exposed to anti-glucagon primary antibody. (C) ATCC αTC1-6 cells immunostained with
a mouse anti-glucagon primary antibody (1:100).
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Figure 4: qPCR analysis of ATCC αTC1-6 cell cDNA. Genes are listed by common
names followed by scientific names in parentheses. The genes encoding glucagon,
Kir6.2, SUR1, and SYT7 were detected. Genes encoding the GABAA receptor, an
agatoxin-sensitive voltage-gated calcium channel, β-1 adrenergic receptor, and β-2
adrenergic receptor were below detection limits. All expression is normalized to
GAPDH. Relative expression was determined using the 2ΔCt *10000.
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Effect of Extracellular Glucose Concentrations on Glucagon Secretion in ATCC
αTC1-6 Cells
Previous studies of isolated intact islets have demonstrated that maximal glucagon
secretion occurs at low glucose concentrations within the range of 0 mM-5 mM and that
maximal inhibition of glucagon secretion occurs between 6 mM and 8 mM glucose. As
the extracellular glucose concentration increases from 8 mM to 20 mM, a reduction in
this inhibition is observed (Salehi, Vieira, and Gylfe 2006). Glucagon secretion at
varying glucose concentrations was tested using the dense-core vesicle-targeted ANFGFP plasmid. It is assumed that the GFP fluorescence detected is directly correlated with
the secretion of glucagon. ATCC αTC1-6 cells were stimulated for 10 minutes at room
temperature with test solution containing 2 mM, 5 mM, 8 mM, and 20 mM glucose. The
analysis of the fluorescence of the secreted fraction divided by the fluorescence of the
lysis fraction is depicted as a percentage in Figure 5. Minimal glucagon secretion is
observed at 8 mM glucose. An elevated level of glucagon secretion is observed at low (2
mM glucose) as well as high (20 mM) glucose conditions. There is a significant change
in secretion between 2 mM and 8 mM glucose (p-value<0.05).
Effect of Extracellular Glucose Concentrations on [Ca2+]i in ATCC αTC1-6 Cells
The next set of experiments analyzed the effect that different extracellular glucose
concentrations have on the intracellular Ca2+ activity in the ATCC αTC1-6 cell.
Intracellular Ca2+ activity ([Ca2+]i) was investigated using the ratiometric calcium sensor
Fura-2 AM. Alpha cells are electrically excitable cells as they contain many different ion
channels and are known to have spontaneous action potentials and sporadic Ca2+ influx
under resting conditions (Ramracheya et al. 2010). These experiments characterized the
22

effect that glucose concentration has on the electrical activity, specifically the influx of
calcium. In Figure 6, the cells were initially in a bath of 8 mM glucose establishing a
baseline calcium activity. Next, via bath perfusion, low (2 mM) or high (15 mM) glucose
was applied to the cells. Intracellular calcium activity was monitored for 16.6 minutes.
Prior to the end of data acquisition in all intracellular calcium experiments, a bath
solution containing 60 mM K+ was perfused over the cells to provide a maximal calcium
influx, thus indicating the cells remained healthy throughout the experiment (data not
shown). Following the addition of 2 mM glucose, an increase in calcium oscillations was
observed in 27% of cells analyzed (n=60) and 19% (n=62) after the addition of 15 mM
glucose (Figure 6).
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Figure 5: Glucagon secretion in ATCC αTC1-6 cells at different extracellular
glucose concentrations. 72 hours after cells were transfected with an ANF-GFP plasmid,
the secretion experiment was performed. Data is represented as % of total GFP
fluorescence. Maximal inhibition occurs at 8 mM glucose. Maximal secretion is observed
at 2 mM glucose and 20 mM glucose. Significant change is detected between 2 mM
glucose and 8 mM glucose (p-value<0.05).
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A
340/380 (nm)

2 mM Glucose

Time (Seconds)

B
340/380 (nm)

15 mM Glucose

Time (Seconds)
Figure 6: Effect of glucose on [Ca2+]i in ATCC αTC1-6 cells. Traces are representative
[Ca2+]i responses to 8 mM, 2 mM, and 15 mM extracellular glucose. Calcium activity is
visualized using Fura-2 AM. Cells were imaged in 8 mM glucose for 10 minutes,
followed by perfusion of 2 mM (A) or 15 mM (B) glucose and imaged an additional 16.6
minutes. α-cell [Ca2+]i is expressed as a ratio of 340/380 nm. An increase in [Ca2+]i is
observed in 27% of cells analyzed (n=60) at 2 mM glucose (A) and 19% (n=62) at 15
mM glucose (B).
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Effect of KATP Channel on [Ca2+]i in ATCC αTC1-6 Cells
The KATP channel is thought to be responsible for the regulation of membrane
potential in the pancreatic alpha cell, leading to or preventing action potentials
responsible for glucagon secretion (Rorsman et al. 2014c). The next set of experiments
was directed at analyzing the effect the channel activity has on intracellular calcium
levels. ATCC αTC1-6 cells were loaded with the ratiometric calcium-indicator dye
FURA2-AM. [Ca2+]i signal was recorded every 3 seconds for 10 minutes at 8 mM
glucose. This was followed by a bath perfusion of the KATP channel modulators and
recorded for an additional 16.6 minutes. Figure 7A illustrates the effect of KATP channel
blocker tolbutamide on ATCC αTC1-6 cells. An increase in calcium-spiking activity was
observed in 53% of the cells analyzed (n=74). Figure 7B depicts the effect of the KATP
channel activator diazoxide on ATCC αTC1-6 cells. A decrease in calcium-spiking
activity was observed in 4% of the cells analyzed (n=90).
Effect of a Na+ Channel Blocker on [Ca2+]i in ATCC αTC1-6 Cells
The sodium channels in alpha cells play a major role in reaching action potential,
resulting in the secretion of glucagon (De et al. 2010). The next experiment investigated
the effect the Na+ channel blocker tetrodotoxin (TTX) has on the spontaneous activity of
ATCC αTC1-6 cells in resting solution. ATCC αTC1-6 cells were loaded with the
ratiometric calcium-indicator dye FURA2-AM. [Ca2+]i signal was recorded every 3
seconds for 10 minutes at 8 mM glucose. Next, Tetrodotoxin was applied to the cells via
bath perfusion, and the resultant calcium activity was monitored every 3 seconds for 16.6
minutes. No decrease in intracellular calcium activity was detected (n=97) (Figure 8).
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A
340/380 (nm)

Tolbutamide (1 µM)

Time (Seconds)

B
340/380 (nm)

Diazoxide (100 µM)

Time (Seconds)
Figure 7: Effect of KATP channel modulators on [Ca2+]i in ATCC αTC1-6 cells.
Traces are representative of [Ca2+]i responses to tolbutamide and diazoxide at 8 mM
glucose. Calcium activity is visualized using Fura-2 AM. Cells were imaged in 8 mM
glucose for 10 minutes, followed by perfusion of 8 mM glucose + tolbutamide (100 µM)
(A) or 8 mM glucose + diazoxide (1 µM) (B) and imaged an additional 16.6 minutes. αcell [Ca2+]i is expressed as a ratio of 340/380 nm. An increase in [Ca2+]i is observed in
53% of cells analyzed (n=74) in 8 mM glucose + tolbutamide (A). A decrease in [Ca2+]i
is observed in 4% of cells analyzed (n=90) in 8 mM glucose + diazoxide (B).
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A
340/380 (nm)

TTX (100 nM)

Time (Seconds)
Figure 8: Effect of a Na+ channel blocker on [Ca2+]i in ATCC αTC1-6 cells. Traces
are representative of [Ca2+]i responses to tetrodotoxin at 8 mM glucose. Calcium activity
is visualized using Fura-2 AM. Cells were imaged in 8 mM glucose for 10 minutes,
followed by perfusion of 8 mM glucose + tetrodotoxin (100 nM) and imaged an
additional 16.6 minutes. α-cell [Ca2+]i is expressed as a ratio of 340/380 nm. No change
in [Ca2+]i is observed in any cells analyzed (n=97).

28

Effect of Voltage-gated Ca2+ Channel Blockers on [Ca2+]i in ATCC αTC1-6 Cells
Voltage-gated calcium channels are important for the calcium influx associated
with alpha cell excitability and glucagon secretion (Ramracheya et al. 2010). The next
experiments determined the presence or absence of N-type, P/Q-type, and L-type
channels in ATCC αTC1-6 cells. The cells were loaded with the ratiometric calciumindicator dye FURA2-AM. [Ca2+]i signal was recorded for 10 minutes at 8 mM glucose.
Next, a 2 mM glucose solution was perfused across the cells, followed by an additional
10 minutes of [Ca2+]i signal recording. The calcium channel antagonists were then added
to the perfusion solution. Nifedipine, ω-agatoxin, and ω-conotoxin (CVIC and CVIB)
were used to selectively block L-type, P/Q-type calcium channels, and N-type calcium
channels, respectively. In Figure 9, a representative FURA2-AM experiment shows that
neither ω-conotoxin CVIB (100 nM, n=53) nor ω-conotoxin CVIC (50 nM, n=65) has
any apparent effect on ATCC αTC1-6 cells [Ca2+]i at low glucose levels. Figure 10A
indicates that in 70% of cells analyzed, there was a decrease in calcium oscillations in the
presence of nifedipine (10 µM, n=20) at low glucose concentrations. Figure 10B shows
that 15% of cells exposed to ω-agatoxin (100 µM, n=19) under low glucose
concentrations resulted in a decrease in calcium-spiking activity.
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A

2 mM Glucose

340/380 (nm)

2 mM Glucose
Conotoxin CVIB (100 µM)

Time (Seconds)

B

2 mM Glucose

340/380 (nm)

2 mM Glucose
Conotoxin CVIC (50 µM)

Time (Seconds)
Figure 9: Effect of N-type Ca2+ channel blockers on [Ca2+]i in ATCC αTC1-6 cells.
Traces are representative [Ca2+]i responses to ω-conotoxin CVIB (A) and ω-conotoxin
CVIC (B) at 2 mM glucose. Calcium activity is visualized using Fura-2 AM. α-cell
[Ca2+]i is expressed as a ratio of 340/380 nm. Cells were imaged in 8 mM glucose for 10
minutes, followed first by perfusion of 2 mM for 10 minutes, followed second by
perfusion of 2 mM glucose + ω-conotoxin CVIB (100 µM) and 2 mM glucose + ωconotoxin CVIC (50 µM), and then imaged an additional 10 minutes. No significant
decrease in calcium oscillations is observed.
30

A

2 mM Glucose

340/380 (nm)

2 mM Glucose
Nifedipine (10 µM)

Time (Seconds)

B

2 mM Glucose

340/380 (nm)
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ω-Agatoxin (100 µM)
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Figure 10: Effect of P/Q- and L-type Ca2+ channel blockers on [Ca2+]i in ATCC
αTC1-6 cells. Traces are representative [Ca2+]i responses to nifedipine (A) and ωagatoxin (B) at 2 mM glucose. Calcium activity is visualized using Fura-2 AM. α-cell
[Ca2+]i is expressed as a ratio of 340/380 nm. Cells were imaged in 8 mM glucose for 10
minutes, followed first by perfusion of 2 mM for 10 minutes, followed second by
perfusion of 2 mM glucose + nifedipine (10 µM) and 2 mM glucose + ω-agatoxin (100
µM), and imaged an additional 10 minutes. A decrease in [Ca2+]i is observed in 70% of
cells analyzed (n=20) in the presence of 2 mM glucose + nifedipine (A) and in 15% of
cells analyzed (n=19) in the presence of 2 mM glucose + ω-agatoxin (B).
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Effect of cAMP on Intracellular Ca2+ Activity in ATCC αTC1-6 cells
cAMP is known to potentiate glucagon secretion in rodent alpha cells through a
PKA-dependent pathway as well as through Epac2, a PKA-independent pathway (De et
al. 2010). Experiments were performed to test how each pathway affects the intracellular
calcium activity of the ATCC αTC1-6 cells. ATCC αTC1-6 cells were loaded with the
ratiometric calcium-indicator dye FURA2-AM. [Ca2+]i signal was recorded for 10
minutes at 8 mM glucose, followed by a perfusion of the cAMP modulators and recorded
for an additional 16.6 minutes. First, forskolin, which increases cAMP by activating
adenylyl cyclase in conjunction with the non-selective phosphodiesterase inhibitor
IBMX, was applied to the cells. 35% of cells analyzed (n=55) showed an increase in
intracellular calcium activity following the addition of forskolin/IBMX (Figure 11A).
Next, 6-Bnz-cAMP, a cell permeable cAMP analog that selectively activates the cAMPdependent PKA pathway, was applied. 2% of cells analyzed (n=72) showed an increase
in intracellular calcium activity following the addition of 6-Bnz-cAMP (Figure 11B).
Finally, 8-pCPT-2'-O-Me-cAMP, a cell permeable cAMP analog that selectively activates
the EPAC signaling pathway, was tested. 13% of cells analyzed (n=55) showed in
increase in intracellular calcium activity following the addition of 8-pCPT-2'-O-MecAMP (Figure 11C).
Effect of cAMP Agonists on Glucagon Secretion in ATCC αTC1-6 Cells
The previous experiments indicated that, to varying degrees, an increase in cAMP
agonists led to an increase in intracellular calcium. To determine if the increases in
cAMP and [Ca2+]i are linked to an increase in glucagon secretion, the following
experiment was performed. Using the ANF-GFP system for glucagon secretion analysis,
32

three conditions were tested: 8 mM glucose, the cAMP agonist forskolin/IBMX in 8 mM
glucose, and the cAMP inhibitor Rp-8-Br-cAMPS in 8 mM glucose. No significant
difference was observed among any of the conditions (Figure 12).
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340/380 (nm)

Forskolin/IBMX (50 µM/10 µM)

Time (Seconds)

B
340/380 (nm)

6-Bnz-cAMP (10 µM)

Time (Seconds)

C
340/380 (nm)

8-pCPT-2'-O-Me-cAMP (10 µM)
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Figure 11: Effect of cAMP modulators on [Ca2+]i in ATCC αTC1-6 cells. Traces are
representative of [Ca2+]i responses to forskolin/IBMX (A), 6-Bnz-cAMP (B), and 8pCPT-2'-O-Me-cAMP (C) at 8 mM glucose. Calcium activity is visualized using Fura-2
AM. Cells were imaged in 8 mM glucose for 10 minutes, followed by perfusion of 8 mM
glucose + forskolin/IBMX (50 µM), 8 mM glucose + 6-Bnz-cAMP (20 µM), and 8pCPT-2'-O-Me-cAMP (10 µM), then imaged an additional 16.6 minutes. α-cell [Ca2+]i is
expressed as a ratio of 340/380 nm. An increase in [Ca2+]i is observed in 35% of cells
analyzed (n=55) in the presence of forskolin/IBMX, 2% (n=72) in the presence of 6-BnzcAMP, and 13% (n=55) in the presence of 8-pCPT-2'-O-Me-cAMP.
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Figure 12: Glucagon secretion in ATCC αTC1-6 cells stimulated by cAMP
modulators. The cAMP agonist forskolin/IBMX and cAMP antagonist RP-8-Br-cAMPS
were analyzed and compared to 8 mM glucose. 72 hours after cells were transfected with
an ANF-GFP plasmid, the secretion experiment was performed. Data is represented as %
of total GFP fluorescence. No significant difference was observed among any of the
conditions.
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DISCUSSION
Tumor cell lines are appealing for use in scientific research because they are cost
effective, readily available, and not encumbered by the ethical concerns of working with
primary tissue. However, in order for a tumor cell line to be considered an appropriate
model system for endocrine research, it must retain the functionality of the primary
endocrine cell and meet the following criteria: (1) Be able to detect characteristic
physiological change through receptors that respond to this change and regulate secretion
in the endocrine cell. (2) Possess channel complexes that respond to the extracellular
signal and (3) Have a functional signal transduction pathway (i.e., appropriate second
messenger system). The objective of this study was to analyze how the tumor cell line
clone αTC1-6 obtained from ATCC responds to a change in circulating glucose levels
and the resulting effect on the release of glucagon, the presence and activity of important
ion channels in glucose-sensing and glucagon secretion, and the function of the cAMP
signaling pathway leading to glucagon secretion.
Confirmed Expression of Glucagon in ATCC αTC1-6 Cells
The pancreatic alpha cell is responsible for the regulated secretion of the peptide
hormone glucagon in response to hypoglycemia. This secretion of glucagon initiates the
synthesis and mobilization of glucose, returning the blood-glucose concentrations to
levels within the normal range. Our results indicate that the gene for glucagon is
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expressed in high abundance in the clonal cell line ATCC αTC1-6 (Figure 4) and is
transcribed into protein (Figure 3).
Expression Detected for Synaptotagmin 7, but No Expression Detected for the
Adrenergic Receptor in ATCC αTC1-6
The pancreatic alpha cell is responsible for secreting glucagon when there is a
decrease in circulating glucose levels in the blood. The hormone is packaged into densecore vesicles and secreted in a Ca2+-dependent manner following the binding of calcium
to the Ca2+-sensor synaptotagmin 7. Our results indicate that the gene encoding
synaptotagmin 7 is present in ATCC αTC1-6 cells (Figure 4).
An important paracrine regulator of the alpha cell is the neurotransmitter
epinephrine. Research has shown that epinephrine stimulates glucagon secretion through
the activation of the β-1 and β-2 adrenergic receptor (De et al. 2010). Our results indicate
the genes encoding the β-1 and β-2 adrenergic receptors are not detectable in the ATCC
αTC1-6 cells (Figure 4).
Increase in Intracellular Calcium Oscillations Coupled with Glucagon Secretion at
Low Levels of Glucose Concentration
The alpha and beta cells in the pancreas work in coordination to maintain normal
blood-glucose levels. The ability of the alpha cell to detect a drop in circulating glucose is
vital in regulating glycemic levels in the blood. At resting glucose concentrations (8
mM), minimal calcium oscillations were observed along with correlating minimal
glucagon secretion. At low glucose concentrations (2 mM), an increase in calcium
activity was observed and was associated with an increase in glucagon secretion (Figure
5). These results demonstrate that ATCC αTC1-6 exhibits a glucose-mediated response to
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glucagon secretion. However, the magnitude of glucagon secretion at low glucose levels
was much smaller than anticipated from an endocrine cell, and we are most likely
observing basal secretion in all conditions tested (Rorsman et al. 2014a). This indicates
that the regulated secretory pathway in the ATCC cells is present, but impaired.
Voltage-gated KATP and P/Q-type Calcium Channel Activity Present, but TTXsensitive Na+ Channel Absent in ATCC αTC1-6 Cells
Ion channels play an important role in alpha cell activity during the response to a
change in extracellular glucose. In low glucose conditions, glucagon secretion is
increased due to low activity of KATP channels, resulting in the firing of large-amplitude
action potentials that inactivate nearby Na+ channels. The results of this study confirm the
presence of the genes encoding the subunits of the KATP channel, SUR1 and KCNJ11, in
ATCC αTC1-6 cells (Figure 4). Intracellular calcium experiments also indicated the
channel was present and active. Tolbutamide, a KATP channel inhibitor, increased
intracellular calcium activity (Figure 7A). Alternatively, the KATP channel activator
diazoxide decreased the calcium oscillation activity (Figure 7B).
Brief or partial opening of KATP channels hyperpolarizes the membrane to a
negative membrane potential and removes the nearby Tetrodotoxin-sensitive Na+ channel
inactivation. Intracellular calcium experiments indicated there was no effect on the
calcium spiking using the drug Tetrodotoxin in ATCC αTC1-6 cells (Figure 8). If the
channel were present, a decrease in the spontaneous calcium activity in the cell would be
expected. This result could indicate that the Tetrodotoxin-sensitive channel is not present
in this cell line or it is not responsible (or activity is not detectable) for the spontaneous
spiking at 8 mM glucose.
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Following the removal of the inactivation of the Tetrodotoxin-sensitive Na+
channel, voltage-gated T-type Ca2+ channels open and the resultant calcium influx
depolarizes the membrane. When the membrane potential reaches action potential
threshold, a large population of P/Q-type channels is able to trigger calcium influx and
glucagon secretion. The gene for the ω-agatoxin IVA-sensitive P/Q-type Ca2+ channel,
CACNA1A, was not detected in ATCC αTC1-6 cells (Figure 4). This implies that either
there is no message for the gene (CACNA1A) or that it is below the detection limit using
qPCR as a method of analysis. However, the decrease in calcium oscillations observed at
2 mM glucose suggests that there is protein expression and functional channel activity
(Figure 10).
cAMP-Induced Intracellular Calcium Not Coupled to Glucagon Secretion in ATCC
αTC1-6 Cells
In endocrine cells, cAMP is an intracellular second messenger activated by the
binding of hormones to G protein-coupled receptors (GPCRs). cAMP exerts many of its
physiological effects by activating cAMP-dependent protein kinase (PKA) or exchange
protein activated by cAMP (Epac), which regulates the functions of downstream protein
targets.
The experiments in this study revealed that all three pharmacological drugs that
increase the production of cAMP and activate the PKA-dependent and Epac-dependent
pathways leading to glucagon secretion increased calcium oscillations in ATCC αTC1-6
cells at 8 mM glucose (Figure 11). However, the secretion assay indicated that this
increase in cAMP activity did not result in an increased secretion of glucagon (Figure
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12). These results suggest that all required exocytosis machinery for cAMP secretion is
not present in the ATCC αTC1-6 cells.
Limitations of Immortal Cell Lines Used for Biological Study
A common problem when using an immortal cell line such as the one used in
these experiments is the evolution of the functional characteristics of the cells. The most
prominent example of this type of evolution is the HeLa cell line. The first immortal cell
line, HeLa, was derived from a cervical tumor and has been used in scientific research for
over 70 years. Over time, however, researchers have discovered variation in new and old
stocks of HeLa cells, thus limiting the cell line for experimental usage (Sato et al. 2016).
Unending proliferation can be beneficial for analysis, but with the increased cellular
division, there is a higher probability of phenotypic drift (Geraghty et al. 2014). As a
result, clonal cell lines must be continually evaluated for changes in the expected
functional properties of the primary cells when used for scientific research.
Major Conclusions
The focus of this study was to evaluate the clonal pancreatic alpha cell line ATCC
αTC1-6 for use as a model cell line to study glucagon secretion. Our research shows that
the ATCC αTC1-6 cell line has not retained essential functional characteristics of the
original alpha cells. While several important alpha cell components are present (i.e.,
production of glucagon, KATP channel activity, and voltage-gated calcium channels), it
does not appear to have completely functional glucagon secretion via glucose sensing, a
cAMP-mediated glucagon secretion pathway, a Tetrodotoxin-sensitive sodium channel,
or the expected adrenergic receptor.
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Due to these shortcomings, it has been determined that the ATCC α-TC1-6 cell
line is not a good model system for the study of regulated glucagon secretion in
pancreatic alpha cells.
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APPENDIX A: PHARMACOLOGICAL DRUGS USED IN EXPERIMENTS
Drug

Supplier

Working
Concentration

Stock
Concentration

Stock
Solvent

Forskolin

Sigma-Aldrich

50 µM

50 µM

DMSO

IBMX

Sigma-Aldrich

10 µM

50 mM

DMSO

8-pCPT-2'O-MecAMP

Sigma-Aldrich

10 µM

50 mM

Water

6-BnzcAMP

Sigma-Aldrich

10 µM

10 mM

Water

ωConotoxin
CVIB

Alomone Labs

100 nM

100 µM

Cytochrome
C

ωConotoxin
CVIC

Alomone Labs

50 µM

50 nM

Cytochrome
C

ω-Agatoxin

Alomone Labs

100 µM

200 nM

Cytochrome
C

Nifedipine

Sigma-Aldrich

10 µM

2.31 mM

95%
Ethanol

TTX

Sigma-Aldrich

100 nM

1 mM

Water

Tolbutamide Sigma-Aldrich

1 µM

10 mM

DMSO

Diazoxide

100 µM

200 mM

DMSO

Sigma-Aldrich
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APPENDIX B: LIST OF ABBREVIATIONS
Abbreviation

Full Name

[Ca2+]i
AC

Intracellular calcium activity
Adenylyl cyclase

ANF-GFP

Atrial natriuretic peptide-green
fluorescent protein

ATCC

American Type Culture Collection

ATP/ADP

Adenosine triphosphate/adenosine
diphosphate

BSA
cAMP
cDNA
DNA
ECL
Epac
GABA

Bovine serum albumin
Cyclic adenosine monophosphate
Complementary deoxyribonucleic acid
Deoxyribonucleic acid
Entactin-collagen IV-laminin
Exchange protein activated by cAMP
γ-aminobutyric acid

GAPDH

Glyceraldehyde-3-phosphate
dehydrogenase

GEF
GLP-1
GLUT2
GPCR
HBSS
IBMX
KATP Channel
mRNA
PBS
PFA
PIK3
PKA
qPCR
SYT7
TTX

Guanine nucleotide exchange factor
Glucagon-like peptide 1
Glucose transporter 2
G-protein coupled receptors
Hanks balanced salt solution
3-isobutyl-1-methylxanthine
ATP-sensitive potassium channel
Messenger ribonucleic acid
Phosphate buffered solution
Paraformaldehyde
Phosphoinositide 3-kinase
Protein kinase A
Quantitative polymerase chain reaction
Synaptotagmin 7
Tetrodotoxin

46

